tert-Butyl 9-bromo-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate

Catalog No. :
ACLYQP565
CAS No. :
2056247-62-0
Molecular Formula :
C16H19BrN2O2
Molecular Weight :
351.24

IUPAC Name:tert-butyl 9-bromo-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate

tert-Butyl 9-bromo-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 9-bromo-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate
IUPAC Nametert-butyl 9-bromo-1,3,4,5-tetrahydro-2H-pyrido[4,3-b]indole-2-carboxylate
MDL No.MFCD31713955
Molecular FormulaC16H19BrN2O2
Molecular Weight351.24
SMILESO=C(N(C1)CCC(N2)=C1C3=C2C=CC=C3Br)OC(C)(C)C
InChI KeyORRIQYXZYAYDPD-UHFFFAOYSA-N
Synonym9-Bromo-1,3,4,5-tetrahydro-pyrido[4,3-b]indole-2-carboxylic acid tert-butyl ester;2H-Pyrido[4,3-b]indole-2-carboxylic acid, 9-bromo-1,3,4,5-tetrahydro-, 1,1-dimethylethyl ester
CAS No.2056247-62-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLYQP565 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLYQP565 route product structure diagram
    ACLYQP5652056247-62-0
Inquiry

2. ACLYQP565 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUWFV973 route compound structure diagram
    ACUWFV97327246-81-7 In Stock
  4. Then
  5. ACLYQP565 route product structure diagram
    ACLYQP5652056247-62-0
Inquiry

Comments (0)